SCHEMBL8926400

SCHEMBL8926400

CCOC(=O)N1CCc2c(Cl)ccc3oc(Cn4cc(Cl)cn4)c(c23)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 3/20 0.38
TSHR P16473 1/20 0.38
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
TP53 P04637 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
POLB P06746 1/20 0.36
PKM P14618 1/20 0.35
KMT2A Q03164 2/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
RXFP1 Q9HBX9 2/20 0.35
LMNA P02545 2/20 0.35
PABPC1 P11940 1/20 0.35
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9378909 0.82 ADRA2A (0.41) ALDH1A1KDM4ETSHRTP53SMN1; SMN2
SCHEMBL8927561 0.81 ADRA2A (0.54) ALDH1A1KDM4ETP53SMN1; SMN2POLB
SCHEMBL8927560 0.81 ADRA2A (0.43) ALDH1A1KDM4ETSHRTP53SMN1; SMN2
Hydrochloric Acid SCHEMBL8927261 0.81 ADRA2A (0.53) ALDH1A1KDM4ETSHRTP53SMN1; SMN2
SCHEMBL10473943 0.77 LMNA (0.39) ALDH1A1KDM4ETSHRTP53SMN1; SMN2
SCHEMBL9382500 0.77 ADRA2A (0.59) ALDH1A1KDM4ETSHRTP53SMN1; SMN2
SCHEMBL9380249 0.76 ALDH1A1 (0.43) ALDH1A1KDM4ETSHRTP53SMN1; SMN2
SCHEMBL9382761 0.76 KDM4E (0.43) ALDH1A1KDM4ETSHRTP53SMN1; SMN2
SCHEMBL9384131 0.75 ERN1 (0.39) ALDH1A1KDM4ETSHRTP53SMN1; SMN2
SCHEMBL9378346 0.75 ADRA2A (0.40) ALDH1A1KDM4ETSHRTP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5599810-A ADMINISTERING IN TREATMENT OF BENIGN PROSTATIC HYPERTROPHY, PERIPHERAL VASCULAR DISEASE AND CONGESTIVE HEART FAILURE SMITHKLINE BEECHAM CORPORATION (US) 1997-02-04 US disclosed
EP-0684949-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1995-12-06 EP disclosed
EP-0684949-A4 CHEMICAL COMPOUNDS. SMITHKLINE BEECHAM CORP (US) 1995-10-13 EP disclosed
WO-1994019354-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1994-09-01 WO disclosed